IVERIC bio (ISEE) Financials

$39.95

$0.00 (0.00%)

As on 11-Jul-2023 09:30EDT

Market cap

$5,512 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	39.64	34.84
Gross Profit	--	--	--	--	-39.64	-34.84
Operating Expenses	229.08	189.91	114.76	88.74	61.27	65.35
Operating Profit (EBIT)	-229.08	-189.91	-114.76	-88.74	-61.27	-65.35
Other Income	0.58	2.43	-0.01	-0.01	0.15	-0.02
Profit before Tax	-222.90	-185.21	-114.52	-88.24	-58.97	62.02
Provision for Tax	-10.77	-9.47	-0.28	-3.70	-0.11	-1.06
Profit after Tax (Net Income)	-212.14	-175.75	-114.24	-84.55	-58.86	63.09
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-222.90	-185.21	-114.52	-84.55	-58.86	63.09

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	477.05	534.75	360.50	191.47	117.15	123.96
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	96.99	96.58	0.62	0.06	6.12	--
Current Liabilities	39.37	35.59	28.21	25.13	12.98	13.21
Total Liabilities	652.78	666.82	389.36	216.75	130.19	137.17

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	1.86	4.00	1.87	0.15	1.56	3.88
Current Assets	611.54	662.83	387.49	216.60	128.62	133.29
Total Assets	652.78	666.92	389.33	216.66	130.14	137.17
Total Debt*	97.76	97.77	1.57	0.12	0.50	--
Net Current Assets	572.17	627.24	359.28	191.47	115.64	120.08

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-163.77	-98.56	-66.10	-48.49	-41.91
Cash Flow from Investing Activities	--	-50.28	21.30	-143.81	0.15	0.15
Cash from Financing Activities	--	428.91	272.34	150.58	42.84	6.14
Net Cash Inflow / Outflow	--	214.86	195.07	-59.33	-5.50	-35.77

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.68	-1.40	-0.99	-0.91	-1.33	1.59
Cash EPS ($)	--	-1.40	-0.99	-0.91	-1.32	1.59
Adjusted Book Value ($)	--	4.27	3.13	2.06	2.64	3.12
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.31	-0.86	-0.71	-1.09	-1.06
Free Cash Flow per Share ($)	--	-1.31	-0.86	-0.71	-1.09	-1.06

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-35.34	-41.27	-54.68	-48.72	77.89
ROE (%)	-57.58	-39.26	-41.39	-54.79	-48.82	77.89
ROA (%)	-41.41	-33.28	-37.70	-48.74	-44.03	40.34
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-36,512.56	-7,229.33	1,142,380.00	1,409,116.67	-38,979.47	-394,293.75
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	-87.19	-65.49	-29.32	-44.82	-198.79	-43.35
Net Profit Growth (%)	-73.89	-53.84	-35.12	-43.64	-193.30	-44.76
EPS Growth (%)	-48.14	-0.41	-0.09	0.31	-1.83	-0.50
Book Value Growth (%)	24.04	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-15.27	-16.84	-7.59	-6.47	0.75
Price / Book Value	3.81	5.02	5.34	3.35	3.25	0.38
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.67	-11.10	-13.46	-4.87	-4.19	-1.34
Close Price ($)	24.33	21.41	16.72	6.91	8.58	1.20
High Price ($)	26.35	24.33	19.32	8.79	8.97	4.50
Low Price ($)	8.85	8.85	4.96	2.64	0.91	1.02
Market Cap ($ Cr)	5,512.18	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.20	0.18	0.00	0.00	0.00	--
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	--
Current Ratio	15.53	18.63	13.74	8.62	9.91	10.09
Quick Ratio	15.53	--	--	--	--	--
Interest Coverage	-58.55	-83.88	-418.82	-139.30	-24.87	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	52.97	70.35
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.